Ligand Pharmaceuticals | LGND - Market Capitalization

Stock Price
213.21
Daily Change
-5.77 -2.63%
Monthly
-4.49%
Yearly
103.95%
Q2 Forecast
208.92

Ligand Pharmaceuticals reported $3.88B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
Amgen USD 189.89B 13.64B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.7B 920M May/2026
Baxter International USD 8.67B 1.15B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Enviri Corporation USD 1.45B 423M Dec/2025
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 15.56B 19.73B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
Ligand Pharmaceuticals USD 3.72B 257M May/2026
MacroGenics USD 102M 4M Dec/2025
Merck USD 297.1B 35.84B Mar/2026
Pacira USD 915M 149M Mar/2026
Pfizer USD 147.4B 6.42B May/2026
Veracyte USD 2.59B 16M May/2026